Oral treatment of parenchymal central nervous system neuroborreliosis - are we there yet?

European Journal of Neurology

Volumn 21, Issue 9, 2014, Pages 1147-1148

  Halperin, J J ^a,b  

^a Overlook Medical Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ANTIMICROBIAL THERAPY; BLOOD BRAIN BARRIER; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; EDITORIAL; HUMAN; LYME DISEASE; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; PRIORITY JOURNAL; COMPLICATION; ENCEPHALITIS; FEMALE; INTRACRANIAL HYPERTENSION; LYME NEUROBORRELIOSIS; MALE; VASCULITIS;

ANTI-BACTERIAL AGENTS; DOXYCYCLINE; ENCEPHALITIS; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; LYME NEUROBORRELIOSIS; MALE; MYELITIS; VASCULITIS;

EID: 84905037711     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12440     Document Type: Editorial

References (8)

1. Bremell D, Dotevall L. Oral doxycycline for Lyme neuroborreliosis with encephalitis, myelitis, vasculitis or pseudotumor cerebri. Eur J Neurol 2014; 21: 1162-1167.
2. Ogrinc K, Lotric-Furlan S, Maraspin V, et al. Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis 2013; 57: 501-509.
3. Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 2005; 37: 449-454.
4. Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology 2007; 69: 91-102.
5. Ljostad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008; 7: 690-695.
6. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-16, e1-4.
7. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089-1134.
8. Halperin J. Lyme disease - neurology, neurobiology and behavior. Clin Infect Dis 2014; 58: 1267-1272.